RU2011112243A - METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS - Google Patents
METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS Download PDFInfo
- Publication number
- RU2011112243A RU2011112243A RU2011112243/05A RU2011112243A RU2011112243A RU 2011112243 A RU2011112243 A RU 2011112243A RU 2011112243/05 A RU2011112243/05 A RU 2011112243/05A RU 2011112243 A RU2011112243 A RU 2011112243A RU 2011112243 A RU2011112243 A RU 2011112243A
- Authority
- RU
- Russia
- Prior art keywords
- prevention
- experimental animals
- subcutaneously
- systemic amyloidosis
- protein preparation
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ профилактики системного амилоидоза и его нефропатической формы у экспериментальных животных, включающий введение сирийским хомякам белкового препарата подкожно и амилоидопротекторного препарата, отличающийся тем, что в качестве белкового препарата вводят нативную человеческую плазму смешанную с адъювантом фрейнда в равных пропорциях, инъекции осуществляют в симметричные подмышечные и паховые области и внутрибрюшинно из расчета 0,1 мл в каждую точку, однократно, а в качестве амилоидопротектора используют галавит, вводимый им одновременно через день подкожно в дозе 0,28 мг/кг в течение 60 дней. A method for the prevention of systemic amyloidosis and its nephropathic form in experimental animals, comprising administering to the Syrian hamsters a protein preparation subcutaneously and an amyloidoprotective drug, characterized in that native human plasma mixed with freund's adjuvant in equal proportions is administered as a protein preparation, injections are carried out in symmetrical axillary and inguinal area and intraperitoneally at the rate of 0.1 ml at each point, once, and as an amyloidoprotector use galavit, introduced by him dnovremenno subcutaneously every other day at a dose of 0.28 mg / kg for 60 days.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011112243/14A RU2473133C2 (en) | 2011-03-30 | 2011-03-30 | Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011112243/14A RU2473133C2 (en) | 2011-03-30 | 2011-03-30 | Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011112243A true RU2011112243A (en) | 2012-10-10 |
RU2473133C2 RU2473133C2 (en) | 2013-01-20 |
Family
ID=47079079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011112243/14A RU2473133C2 (en) | 2011-03-30 | 2011-03-30 | Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2473133C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2657844C1 (en) * | 2017-01-09 | 2018-06-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method of treatment an experimental amyloid cardiopathy in rats |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
RU2270672C1 (en) * | 2004-09-15 | 2006-02-27 | Северо-Осетинская государственная медицинская академия | Method for prophylaxis and treatment of systemic amyloidosis and nephropathic form thereof in experimental animals |
ES2352801T3 (en) * | 2005-12-22 | 2011-02-23 | Kiacta Sàrl | TREATMENT OF DIABETIC NEPHROPATHY. |
RU2312663C1 (en) * | 2006-02-21 | 2007-12-20 | Закрытое акционерное общество "Центр современной медицины "Медикор" | Method for treatment of acute destructive pancreatitis |
RU2383342C1 (en) * | 2008-07-16 | 2010-03-10 | Наталья Эдуардовна Романцева | Method of treating pulmonary tuberculosis in hiv-infection patients |
RU2381797C1 (en) * | 2008-11-05 | 2010-02-20 | Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию | Method for prevention of systemic amyloidosis and its nephropatic form in experimental animals |
-
2011
- 2011-03-30 RU RU2011112243/14A patent/RU2473133C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2473133C2 (en) | 2013-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ630790A (en) | Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes | |
TR201900649T4 (en) | Mrna therapy for the treatment of ocular diseases. | |
EA201490254A1 (en) | COMBINED TREATMENT OF HEPATITIS C | |
EA201591715A1 (en) | COMBINED THERAPY WITH THE USE OF 7-BENZYL-10- (2-METHYLBENZYL) -2,6,7,8,9,10-HEXAHYDROIMIDAZO [1,2-a] PYRIDO [4,3-d] PYRIMIDIN-5 (3H) -SHE IS | |
AR082150A1 (en) | N-ETIL-N-Phenyl-1,2-DIHIDRO-4-HYDROXI-5-CHLORINE-1-METHYL-2-OXOQUINOLIN-3-CARBOXAMIDE DEUTERADA, SALTS AND USES OF THE SAME, TREATMENT METHOD, COMPOUND BLEND, COMPOSITION PHARMACEUTICS, PREPARATION PROCESS, ENRICHED COMPOUND WITH DEUTERIO | |
JP2015518818A5 (en) | ||
RU2013156378A (en) | 4-amino-5-fluoro-3- [6- (4-methylpiperazin-1-yl) -1h-benzimidazole-2-yl] -1h-quinolin-2-one for use in the treatment of adenocystic carcinoma | |
EA201791727A1 (en) | 7-BENZYL-4- (2-METHYLBENZIL) -2,4,6,7,8,9-HEXAHYDROIMIDAZO [1,2-A] PYRIDO [3,4-E] PYRIMIDIN-5 (1H) -OH, ITS ANALOGUES AND SALTS AND METHODS OF THEIR APPLICATION IN THERAPY | |
RU2014150942A (en) | TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE | |
RU2015116264A (en) | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN PATIENTS WITH DIABETES | |
RU2013123646A (en) | COMBINED COMPOSITION | |
FI3383385T4 (en) | Melflufen dosage regimens for cancer | |
RU2014124171A (en) | MEDICINE FOR THERAPEUTIC TREATMENT AND / OR IMPROVEMENT OF SEPSIS | |
AR080096A1 (en) | COMBINED TREATMENT OF PANCREAS CANCER WITH GEMCITABIN AND MASITINIB | |
EA201691055A1 (en) | PREPARATIONS AND METHODS OF TREATMENT OF GD2-POSITIVE CANCER | |
EA201490045A1 (en) | DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA | |
AR093908A1 (en) | FUSION OF HUMAN AND ALBUMINE GROWTH HORMONE, FORMULATION AND USES OF THE SAME | |
RU2015112121A (en) | MI-RNA AND THEIR APPLICATION IN METHODS AND COMPOSITIONS FOR TREATMENT AND / OR PREVENTION OF EYE CONDITIONS | |
EA201690057A1 (en) | OSTEOPONTIN MILK MAMMALS TO IMPROVE IMMUNOLOGICAL REACTIVITY | |
EA201791895A1 (en) | DOSES AND METHODS OF ADMINISTRATION TELAVANCIN | |
MY193963A (en) | Composition for treating joint diseases and kit containing same | |
EA201591653A1 (en) | COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL | |
RU2011112243A (en) | METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | |
RU2019109154A (en) | PHARMACEUTICAL COMPOSITION FOR THERAPY OF GROWTH HORMONE DEFICIENCY, CONTAINING THE FUEL PROTEIN hGH | |
RU2010153722A (en) | METHOD FOR INCREASING EFFECTIVENESS OF TREATMENT OF HYPOFUNCTIONS OF OVARIES IN COWS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130331 |